Clinical Trials Browser

Phase 1/2 × Neoplasms × inebilizumab × Clear all

NCT00983619 2020-05-13

A Clinical Study Using MEDI-551 in Adult Participants With Relapsed or Refractory Advanced B-Cell Malignancies

Phase 1/2 Completed

136 enrolled 56 charts

Neoplasms